CX3CL1 and amyotrophic lateral sclerosis: Our results indicate that MSC could provide neuroprotective effects in ALS not only by direct release of CX3CL1 but also by stimulation of astrocytic CX3CL1 secretion and microglial CX3CR1 expression.